Alkem Laboratories Limited
ALKEM
Rang in aandelen
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aandeelprijs
$55.19
Marktkapitalisatie
$6.60B
Verandering (1 dag)
-0.06%
Verandering (1 jaar)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Categorie
Healthcare
P/B-ratio voor Alkem Laboratories Limited (ALKEM)
P/B-ratio op October 2026 TTM: 4.31
Volgens de meest recente financiële rapporten en aandelenkoers van Alkem Laboratories Limited is de huidige P/B-ratio (TTM) 4.31. Eind 2024 had het bedrijf een P/B-ratio van 5.81.
P/B-ratiohistoriek voor Alkem Laboratories Limited van 2010 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 4.31 | -10.49% |
| 2025 | 4.82 | -16.94% |
| 2024 | 5.81 | 29.38% |
| 2023 | 4.49 | -10.43% |
| 2022 | 5.01 | 11.63% |
| 2021 | 4.49 | -0.54% |
| 2020 | 4.51 | 17.52% |
| 2019 | 3.84 | -18.59% |
| 2018 | 4.72 | -20.04% |
| 2017 | 5.90 | 34.33% |
| 2016 | 4.39 | -20.25% |
| 2015 | 5.51 | -11.47% |
| 2014 | 6.22 | -10.59% |
| 2013 | 6.96 | -19.73% |
| 2012 | 8.67 | -25.08% |
| 2011 | 11.57 | -15.57% |
| 2010 | 13.71 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 16.85% |
IN
|
